R

RenovoRx
D

RNXT

1.30000
USD
0.00
(0.00%)
مفتوح الان
حجم التداول
897
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
58,668,360
المقالات
المزيد

العنوان: RenovoRx

القطاع: الرعاية الصحية
الصناعة: Biotechnology
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.